Abstract
Acinetobacter baumannii has emerged as an important opportunistic pathogen equipped with a growing number of antibiotic resistance genes. Our study investigated the molecular epidemiology and antibiotic resistance features of 28 consecutive carbapenem-resistant clinical isolates of A. baumannii collected throughout Sweden in 2012 and 2013. The isolates mainly belonged to clonal complexes (CCs) with an extensive international distribution, such as CC2 (n = 16) and CC25 (n = 7). Resistance to carbapenems was related to blaOXA-23 (20 isolates), blaOXA-24/40-like (6 isolates), blaOXA-467 (1 isolate), and ISAba1-blaOXA-69 (1 isolate). Ceftazidime resistance was associated with blaPER-7 in the CC25 isolates. Two classical point mutations were responsible for resistance to quinolones in all the isolates. Isolates with high levels of resistance to aminoglycosides carried the 16S rRNA methylase armA gene. The isolates also carried a variety of genes encoding aminoglycoside-modifying enzymes. Several novel structures involved in aminoglycoside resistance were identified, including Tn6279, ΔTn6279, Ab-ST3-aadB, and different assemblies of Tn6020 and TnaphA6. Importantly, a number of circular forms related to the IS26 or ISAba125 composite transposons were detected. The frequent occurrence of these circular forms in the populations of several isolates indicates a potential role of these circular forms in the dissemination of antibiotic resistance genes.
INTRODUCTION
During the last 4 decades, Acinetobacter baumannii has emerged as a major opportunistic pathogen responsible for a wide range of hospital-acquired infections, such as ventilator-associated pneumonia and catheter-related bloodstream infections (1). Multilocus sequence typing (MLST) demonstrated a wide geographical prevalence of particular clonal complexes (CCs) in the global population of A. baumannii (2). According to the Institute Pasteur MLST scheme, CC2, CC1, and, recently, CC25 have been playing a major role in the worldwide dissemination of A. baumannii (2, 3). Worryingly, A. baumannii has shown a remarkable ability to acquire resistance against different classes of antibiotics (1). Resistance to carbapenems is mainly mediated by the production of carbapenem-hydrolyzing enzymes, usually encoded by horizontally imported genes (4). In this regard, a variety of acquired carbapenemase genes have been detected, including the class A (blaGES-14 and blaKPC), class B (blaIMP, blaVIM, blaSIM-1, and blaNDM), and class D (blaOXA-23-like, blaOXA-24/40-like, blaOXA-58-like, blaOXA-104, blaOXA-143, blaOXA-164, and blaOXA-182) β-lactamases (2, 4, 5). Alternatively, overexpression of the A. baumannii-intrinsic blaOXA-51-like gene has also been responsible for carbapenem resistance in A. baumannii (5). The overexpression is usually due to the acquisition of a strong promoter provided by an insertion sequence (IS) element, ISAba1, inserted upstream of the relevant gene (5). Likewise, resistance to ceftazidime has mainly been mediated by the overexpression of another A. baumannii-intrinsic gene, the blaADC (Acinetobacter-derived cephalosporinase) gene, which has also been related to the acquisition of an upstream strong promoter provided by ISAba1 or other IS elements (4, 6).
The acquisition of genes encoding aminoglycoside-modifying enzymes (AMEs) has been a main cause of resistance to aminoglycosides in A. baumannii (4). Different AME-encoding genes, such as aphA1, aphA6, aphA15, aacC1, aacC2, aacA4, aadB, aadA1, and aadA4, have been detected in clinical isolates of A. baumannii (2, 4). Many of these genes (for example, aacC1, aacA4, and aadA1) are located on class 1 integrons (7). In contrast, the aphA1 and aphA6 genes have always been surrounded by IS elements, forming different composite transposon structures (8, 9). Notably, A. baumannii strains producing the ArmA 16S rRNA methylase have increasingly been reported in the last decade (10). The ArmA enzyme mediates a high level of pan-aminoglycoside resistance, on the basis of the decrease of affinity of the targeted 16S rRNA toward aminoglycosides (11). The armA gene has frequently been surrounded by the putative tnpU and tnpD transposase genes and has repeatedly been found to be plasmid mediated (10, 12). On the other hand, the acquisition of particular chromosomal mutations is the primary mechanism of quinolone resistance in A. baumannii (4). The occurrence of two amino acid substitutions in the quinolone resistance-determining region (QRDR) of the A. baumannii gyrase and topoisomerase IV enzymes has been sufficient for the isolates to obtain a high level of resistance to quinolones (13).
In Sweden, the prevalence of A. baumannii infections has been low and the emergence of multidrug-resistant strains has often been associated with a history of import (14). The ability of A. baumannii to persist in health care settings and the increasing frequency of imports by patients colonized with the bacterium call for enhanced surveillance and attention. This study aimed to characterize the molecular epidemiology and antimicrobial resistance features of a recent collection of carbapenem-resistant A. baumannii clinical isolates collected over a period of 1 and a half years throughout Sweden. In addition, the study expansively investigated the genetic context of particular aminoglycoside resistance genes.
MATERIALS AND METHODS
A. baumannii isolates.
The study included 28 consecutive nonduplicate clinical isolates of A. baumannii collected by 8 diagnostic microbiology laboratories throughout Sweden between April 2012 and November 2013 (Table 1). The isolates were selected on the basis of their resistance to carbapenems (imipenem and/or meropenem), according to the clinical breakpoints defined by the European Committee on Antimicrobial Susceptibility Testing (EUCAST; http://www.eucast.org/clinical_breakpoints/). Species identification was first performed using a commercial Microflex system and MALDI Biotyper (version 3.1) software (Bruker Daltonics, Billerica, MA) and then confirmed by detecting the occurrence of blaOXA-51-like and partial rpoB gene sequences (15, 16).
TABLE 1.
Strain | Sample | Date of isolation (day.mo.yr) | City of isolation | Source of imported strain | MLSTa |
Pulsotype | ||
---|---|---|---|---|---|---|---|---|
Allelic profile | ST | CC | ||||||
A068 | No data | 04.04.2012 | Blekinge | No data | 3-3-2-4-7-2-4 | ST25 | CC25 | Ac-02 |
A069 | Feces | 24.05.2012 | Halland | Thailand | 3-3-2-4-7-2-4 | ST25 | CC25 | Sporadic |
A070 | Tracheal secretion | 08.06.2012 | Stockholm | No data | 27-2-7-2-2-1-2 | ST215 | CC215 | Sporadic |
A071 | Labia major | 02.08.2012 | Skåne | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Sporadic |
A072 | Rectum | 28.09.2012 | Skåne | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Ac-01 |
A074 | Urine | 10.12.2012 | Skåne | No data | 2-1-2-2-2-1-1 | ST636 | Singleton | Ac-03 |
A076 | Rectum | 04.01.2013 | Skåne | No data | 1-1-1-1-5-1-1 | ST1 | CC1 | Sporadic |
A077 | Rectum | 10.01.2013 | Skåne | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Sporadic |
A078 | Tracheal secretion | 05.02.2013 | Våstra Götaland | No data | 1-3-10-1-4-4-4 | ST23 | CC10 | Sporadic |
A079 | No data | 07.02.2013 | Skåne | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Ac-01 |
A080 | Tracheal secretion | 11.03.2013 | Skåne | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Ac-01 |
A082 | Wound | 12.03.2013 | Östergötland | No data | 1-1-1-1-5-1-1 | ST1 | CC1 | Sporadic |
A084 | Groin | 26.03.2013 | Östergötland | Iraq | 2-2-2-2-2-2-2 | ST2 | CC2 | Ac-01 |
A085 | Rectum | 02.04.2013 | Östergötland | Israel | 3-3-2-2-3-1-3 | ST3 | CC3 | Sporadic |
A086 | Rectum | 16.04.2013 | Skåne | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Ac-01 |
A087 | Urine | 23.04.2013 | Västra Götaland | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Sporadic |
A089 | No data | 08.05.2013 | Västernorrland | Thailand | 2-2-2-2-2-2-2 | ST2 | CC2 | Ac-01 |
A091 | Feces | 31.05.2013 | Varmland | Italy | 2-2-2-2-2-2-2 | ST2 | CC2 | Sporadic |
A092 | Blood | 01.08.2013 | Östergötland | No data | 3-3-2-4-7-2-4 | ST25 | CC25 | Ac-02 |
A093 | No data | 02.08.2013 | Östergötland | No data | 3-3-2-4-7-2-4 | ST25 | CC25 | Ac-02 |
A094 | Feces | 02.08.2013 | Östergötland | No data | 3-3-2-4-7-2-4 | ST25 | CC25 | Ac-02 |
A095 | Feces | 14.08.2013 | Stockholm | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Sporadic |
A096 | Thorax | 16.08.2013 | Östergötland | No data | 3-3-2-4-7-2-4 | ST25 | CC25 | Ac-02 |
A097 | Nose | 21.08.2013 | Östergötland | No data | 3-3-2-4-7-2-4 | ST25 | CC25 | Ac-02 |
A099 | Bronchial secretion | 11.10.2013 | Östergötland | No data | 5-2-4-1-3-3-4 | ST85 | CC85 | Sporadic |
A100 | No data | 17.10.2013 | Skåne | No data | 1-1-1-1-5-1-1 | ST1 | CC1 | Sporadic |
A101 | Decubitus sore | 24.10.2013 | Östergötland | No data | 2-2-2-2-2-2-2 | ST2 | CC2 | Ac-01 |
A105 | Bronchial secretion | 21.11.2013 | Stockholm | No data | 2-1-2-2-2-1-1 | ST636 | Singleton | Ac-03 |
MLST, multilocus sequence typing (performed according to the Institute Pasteur scheme); ST, sequence type; CC, clonal complex.
Antimicrobial susceptibility testing.
The MICs of cefotaxime, ceftazidime, imipenem, meropenem, ciprofloxacin, and colistin were determined using Etest (bioMérieux SA, Marcy l'Etoile, France) according to the manufacturer's instructions. The diameters of the zones of inhibition for tobramycin, gentamicin, and amikacin were determined by the agar disk diffusion method using disks from Oxoid (Basingstoke, United Kingdom) and following the guidelines of EUCAST (http://www.eucast.org/antimicrobial_susceptibility_testing/). Susceptibility patterns were interpreted according to the clinical breakpoints defined by EUCAST (http://www.eucast.org/clinical_breakpoints/) for all antibiotics except cefotaxime and ceftazidime, for which the Clinical and Laboratory Standards Institute (CLSI) breakpoints were used (CLSI document M100-S24, 2014 [17]). Isolates showing resistance to ≥3 classes of antibiotics were defined to be multidrug resistant (18).
Genome sequencing and sequence analysis.
Whole DNA genomes were extracted by use of a DNeasy blood and tissue kit (Qiagen, Sollentuna, Sweden) and quantified using a Qubit double-stranded DNA BR assay system (Life Technologies, Stockholm, Sweden). An indexed paired-end library was prepared for all the isolates using a Nextera XT DNA sample preparation kit (Illumina, San Diego, CA, USA), a Nextera XT index kit (Illumina, San Diego, CA, USA), and an Agencourt AMPure XP system (Beckman Coulter, Bromma, Sweden). The library was sequenced using a MiSeq reagent kit (v3) and an Illumina MiSeq system (Illumina, San Diego, CA, USA). All steps of DNA preparation, library construction, and genome sequencing were done according to the manufacturers' instructions. Sequence data were assembled and analyzed using the CLC genomics workbench (v7.0.4; CLC bio, Aarhus, Denmark).
Molecular epidemiology.
The isolates were assigned to sequence types (STs) using the MLST function provided online by the Center for Genomic Epidemiology (http://www.genomicepidemiology.org/) in Denmark (19). The assignment was performed according to the Institute Pasteur's scheme (3). In order to allocate the isolates into CCs, the BURST algorithm, integrated in the Institute Pasteur's MLST website (http://www.pasteur.fr/mlst), was applied to all the allelic profiles in the database under a stringent grouping parameter (profiles that matched the profile of any other member of the group at 6 loci were defined to be a group). Pulsed-field gel electrophoresis (PFGE) was performed using ApaI-digested genomic DNA, as previously described (20). DNA fragments were separated in a CHEF-DRII apparatus (Bio-Rad, Marne LA Coquette, France) at 6 V/cm and 14°C for 20 h with switch times ranging from 5 s to 30 s. Similarities among the PFGE patterns were calculated by the Dice coefficient method (with an optimization of 1% and a position tolerance of 1%) using BioNumerics software (v7.1; Applied Maths, Ghent, Belgium). A PFGE type was defined by a cluster of isolates showing ≥90% similarity or less than 3 band differences (21).
In addition, a phylogenetic analysis based on alignments of the whole-genome single nucleotide polymorphism (SNP) concatenations was performed. The genomes were assembled using ABySS (v2.0; Canada's Michael Smith Genome Sciences Centre, Vancouver, Canada), a de novo assembler designed for short-read sequence data (22). Pairwise alignments were performed using the progressiveMauve algorithm (v12; http://darlinglab.org/mauve/user-guide/progressivemauve.html) and A. baumannii ATCC 17978 as an index strain. Then, all the duo alignments were merged into one multiple-sequence alignment. Nucleotide distances between genomes were calculated using MEGA (v5.13; http://www.megasoftware.net/) and SplitsTree (http://www.splitstree.org/) software. A. baumannii strains ATCC 17978 (sporadic), AYE (CC1), ACICU (CC2), and SDF (sporadic, isolated from a human body louse) were included as reference strains. SplitsTree was also used to generate a phylogenetic NeighborNet graph.
Detection of antibiotic resistance genes and genetic elements.
ResFinder, a search engine hosted on the website of the Center for Genomic Epidemiology (http://www.genomicepidemiology.org/) in Denmark, was used to detect the presence of acquired antimicrobial resistance genes (23). The ResFinder database includes more than 1,700 variants of antibiotic resistance genes (last accessed in March 2015). IS elements were identified using the ISfinder application (24). Plasmids were typed according to the A. baumannii PCR-based replicon typing (AB-PBRT) scheme (25). Plasmid typing was performed using in silico PCR assays followed by sequence analysis of the positive amplicons. Comparative sequence analysis was performed in order to detect the occurrence of amino acid replacements in the QRDRs of GyrA and ParC, using, respectively, the GenBank (GB) sequences of GyrA (GB accession number CAA57655) and ParC (GB accession number CAA65085) produced by quinolone-susceptible isolates as controls (13, 26).
PCR amplification and Sanger sequencing of the amplicons were used to determine the order and orientation of some contigs carrying resistance determinants and to fill in gaps between these contigs, as previously described (27). In addition, the genetic context of particular antibiotic resistance genes and genetic elements was determined by PCR assays and sequencing using more than 120 inwards and outwards, internal and external primers (see Table S1 in the supplemental material). The occurrence of circular forms was detected by PCR assays and sequencing using the outwards internal primers, whereas misplacement of the genetic element in part of the population of each strain was investigated using the inwards external primers (Fig. 1). One thermal cycling program consisting of an initial denaturation at 94°C for 5 min followed by 30 cycles of amplification (denaturation at 95°C for 20 s, annealing at 56°C for 20 s, and extension at 72°C for 2.5 min) and a final extension at 72°C for 8 min was used for all the PCRs.
Nucleotide sequence accession numbers.
Draft genome sequences of all the isolates were deposited in the DDBJ/EMBL/GenBank database under accession numbers SRS925054 (strain A068), SRS926091 and SRS926093 (strains A069 and A070, respectively), SRS927389 to SRS927398 (strains A071 to A084, respectively), SRS927399 and SRS927400 (strains A086 and A087, respectively), SRS927401 (strain A085), SRS927402 to SRS927412 (strains A089 to A101, respectively), and SRS979539 (strain A105). In addition, novel sequences of particular genetic elements were manually annotated and deposited in the DDBJ/EMBL/GenBank database under the following accession numbers: KR535992 (plasmid pA105-1 carrying TnaphA6), KR535993 (plasmid pA105-2 carrying ISAba31 and blaOXA-72), KP881233 to KP881241 (blaADC-73 to blaADC-81, respectively, representing novel variants of blaADC), KT354505 (blaOXA-467, representing a novel variant of blaOXA-58-like), KT317075 (Tn6279 inserted in the orfHPA2 gene of strain A071, representing a subpopulation of this strain), KT317076 (Tn1548-like-1 inserted in the orfHPA2 gene of strain A071, representing a second subpopulation of this strain), KT317077 (IS26 inserted in the orfHPA2 gene of strain A071, representing a third subpopulation of this strain), KT354506 (Tn6279-like chromosomally inserted in strain A070), KT354507 (ΔTn6279 chromosomally inserted in strain A072), KT317078 to KT317084 (circular forms of Tn6279, Tn1548-like-1, Tn6020b-1, Tn6020b-2, Tn6020a-1, Tn6020a-2, and Tn6020a-3, respectively), KT317085 (Tn1548-like-2 inserted in a plasmid), KT317086 (circular form of Tn1548-like-2), and KT317087 (circular form of TnaphA6a). The novel sequences of ST636, blaOXA-467, and ISAba31 were also deposited in the locus/sequence definitions database of the Institut Pasteur Acinetobacter MLST system (http://pubmlst.org/abaumannii/), Lahey Clinic databases of β-lactamases (http://www.lahey.org/Studies/), and the ISfinder database (www-is.biotoul.fr), respectively. The novel Tn6279 transposon was numbered by the curators of the Tn Number Registry (http://www.ucl.ac.uk/eastman/research/departments/microbial-diseases/tn) (28).
RESULTS
Species identification and antimicrobial susceptibility patterns.
Assignment of all the isolates to the A. baumannii species was confirmed by biochemical characterization, presence of the blaOXA-51-like gene, and partial rpoB sequence analysis (see Fig. S1 in the supplemental material). Resistance to meropenem or imipenem was confirmed for all the isolates. However, one isolate (A082) was intermediate to imipenem, while another isolate (A099) was intermediate to meropenem (Table 2). All the isolates showed high levels of resistance (MICs ≥ 32 mg/liter) to ciprofloxacin. Twenty-seven isolates were resistant to cefotaxime and ceftazidime, while only one isolate (A094) was intermediate to cefotaxime and fully susceptible to ceftazidime. Sixteen isolates showed high levels of resistance (diameter of zone of inhibition, 6 mm) to all the three aminoglycosides. The other 12 isolates revealed variable levels of resistance to one or more of the aminoglycosides. All the isolates were defined to be multidrug resistant (18). Colistin was the only antibiotic to which all the isolates were susceptible.
TABLE 2.
Strain | Susceptibility by Etest (MIC [mg/liter]) |
Susceptibility by agar disc diffusion (zone diam [mm]) |
|||||||
---|---|---|---|---|---|---|---|---|---|
MEM | IPM | CIP | CTX | CAZ | CST | TOB10 | GEN10 | AMK30 | |
A068 | R (16) | R (32) | R (>32) | R (>256) | R (>256) | S (0,25) | R (6) | R (6) | R (6) |
A069 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.125) | R (6) | R (6) | R (6) |
A070 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.25) | R (6) | R (6) | R (6) |
A071 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.5) | R (6) | R (6) | R (6) |
A072 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.25) | R (6) | R (6) | R (6) |
A074 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.25) | S (17) | R (6) | R (6) |
A076 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.25) | R (11) | R (6) | S (21) |
A077 | R (>32) | R (>32) | R (>32) | R (>256) | R (>256) | S (0.25) | S (18) | R (6) | S (20) |
A078 | R (>32) | R (>32) | R (>32) | R (>256) | R (>256) | S (0.25) | R (6) | R (6) | R (9) |
A079 | R (>32) | R (>32) | R (>32) | R (>256) | R (>256) | S (0.125) | R (6) | R (6) | R (6) |
A080 | R (>32) | R (>32) | R (>32) | R (>256) | R (>256) | S (0.25) | R (6) | R (6) | R (6) |
A082 | R (16) | I (8) | R (>32) | R (>256) | R (>256) | S (0.25) | R (12) | R (6) | R (9) |
A084 | R (>32) | R (>32) | R (>32) | R (>256) | R (>256) | S (0.5) | S (19) | R (8) | R (8) |
A085 | R (>32) | R (>32) | R (>32) | R (>256) | R (256) | S (0.5) | R (14) | R (10) | I (15) |
A086 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.125) | R (6) | R (6) | R (6) |
A087 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.125) | S (18) | R (6) | R (6) |
A089 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.125) | R (6) | R (6) | R (6) |
A091 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.25) | R (6) | R (6) | R (6) |
A092 | R (32) | R (32) | R (32) | R (256) | R (256) | S (1) | R (6) | R (6) | R (6) |
A093 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.25) | R (6) | R (6) | R (6) |
A094 | R (32) | R (32) | R (32) | I (32) | S (8) | S (0.25) | R (6) | R (6) | R (6) |
A095 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.5) | R (6) | R (6) | R (6) |
A096 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.25) | R (6) | R (6) | R (6) |
A097 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.25) | R (6) | R (6) | R (6) |
A099 | I (8) | R (16) | R (32) | R (256) | R (32) | S (0.125) | S (18) | R (8) | R (10) |
A100 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.125) | R (7) | R (6) | R (8) |
A101 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.125) | S (19) | S (19) | R (10) |
A105 | R (32) | R (32) | R (32) | R (256) | R (256) | S (0.125) | S (19) | R (6) | R (8) |
MEM, meropenem; IPM, imipenem; CIP, ciprofloxacin; CTX, cefotaxime; CAZ, ceftazidime; CST, colistin; TOB10, tobramycin at 10 mg/liter; GEN10, gentamicin at 10 mg/liter; AMK30, amikacin at 30 mg/liter; R, resistant; I, intermediate; S, susceptible. The results were interpreted according to the following clinical breakpoints, as defined by EUCAST (http://www.eucast.org/clinical_breakpoints/) and/or according to the Clinical and Laboratory Standards Institute breakpoints (CLSI document M100-S24, 2014 [17]): for meropenem and imipenem, susceptible was an MIC of ≤2 mg/liter and resistant was an MIC of >8 mg/liter; for ciprofloxacin, susceptible was an MIC of ≤1 mg/liter and resistant was an MIC of >1 mg/liter; for cefotaxime, susceptible was an MIC of ≤8 mg/liter, intermediate was an MIC of 16 to 32 mg/liter, and resistant was an MIC of ≥64 mg/liter; for ceftazidime, susceptible was an MIC of ≤8 mg/liter, intermediate was an MIC of 16 mg/liter, and resistant was an MIC of ≥32 mg/liter; for colistin, susceptible was an MIC of ≤2 mg/liter and resistant was an MIC of >2 mg/liter; for tobramycin at 10 mg/liter, susceptible was an MIC of ≥17 mg/liter and resistant was an MIC of <17 mg/liter; for gentamicin at 10 mg/liter, susceptible was an MIC of ≥17 mg/liter and resistant was an MIC of <17 mg/liter; and for amikacin at 30 mg/liter, susceptible was an MIC of ≥18 mg/liter and resistant was an MIC of <15 mg/liter).
Molecular epidemiology.
The isolates were assigned to ST2/CC2 (n = 12), ST25/CC25 (n = 7), ST1/CC1 (n = 3), ST636/singleton (n = 2), ST215/CC215 (n = 1), ST23/CC10 (n = 1), ST3/CC3 (n = 1), and ST85/CC85 (n = 1) (Table 1). In general, the CCs showed a robust association with particular variants of the intrinsic blaOXA-51-like and blaADC genes. For instance, all the CC25 isolates carried the blaOXA-64 (n = 7) and blaADC-26 (n = 7) variants, whereas blaOXA-66 (n = 13), blaADC-73 (n = 7), and blaADC-30 (n = 6) were exclusively present in isolates from CC2 or CC215. Whole-genome SNP-based phylogenetic analysis identified 4 clades corresponding to CC1, CC2, CC25, and ST636, according to the MLST nomenclature (Fig. 2). The analysis also detected several conflicting phylogenetic signals, represented by reticulate topologies in SplitsTree, possibly related to the occurrence of frequent recombination events. PFGE allocated 15 of the isolates into three groups, namely, Ac-01 (n = 7), Ac-02 (n = 6), and Ac-03 (n = 2), consistent with CC2, CC25, and ST236, respectively (see Fig. S2 in the supplemental material). The remaining 13 isolates had unique PFGE patterns. A linkage between Ac-01 and Ac-02 and two particular laboratories, which may indicate a local spread of outbreak strains, was observed (Table 1).
Antibiotic resistance mechanisms.
Resistance to carbapenems was mediated by blaOXA-23 in 20 isolates, blaOXA-24/40 or blaOXA-72 in 6 isolates, blaOXA-467 (OXA-58-like) in 1 isolate, and ISAba1-blaOXA-69 in 1 isolate (Table 3). Resistance to third-generation cephalosporins was associated with ISAba1-blaADC-like (19 isolates), blaPER-7 (6 isolates), ISAba125-blaADC-81 (1 isolate), and IS6-family-blaADC-77 (1 isolate). It is important to note that the last isolate (A078) carried two blaADC genes; one of them (blaADC-76) was present at the typical chromosomal position for A. baumannii-intrinsic blaADC genes, while the other one (blaADC-77) was located elsewhere and surrounded by two copies of IS6-family. Resistance to quinolones was due to two amino acid substitutions in the QRDRs of GyrA (S83L) and ParC (S80L) in all the isolates. All the 16 isolates with high levels of resistance to amikacin, gentamicin, and tobramycin carried the armA gene (Table 4). In addition, the aacA4, aacC1, aacC2, aadA1, aadB, aphA1, and aphA6 aminoglycoside resistance genes were detected in 4, 9, 7, 10, 2, 16, and 11 isolates, respectively. The isolates also carried a number of streptomycin, macrolide, phenicol, rifampin, or sulfonamide resistance genes (see Tables S2 and S3 in the supplemental material).
TABLE 3.
Strain | Intrinsic genes |
Acquired genes |
||
---|---|---|---|---|
blaADC | blaOXA-51-like | blaOXA (genetic context) | Other(s) | |
A068 | blaADC-26 | blaOXA-64 | blaOXA-23 (Tn2006) | blaPER-7 |
A069 | blaADC-26 | blaOXA-64 | blaOXA-23 (Tn2006) | blaPER-7 |
A070 | ISAba1, blaADC-30 | blaOXA-66 | blaOXA-23 (Tn2006) | blaTEM-1D |
A071 | ISAba1, blaADC-30 | blaOXA-66 | blaOXA-23 (Tn2009) | |
A072 | ISAba1, blaADC-73 | blaOXA-66 | blaOXA-23 (Tn2006) | blaTEM-1D |
A074 | ISAba1, blaADC-74 | blaOXA-66 | XerC/XerD-like, ISAba31, blaOXA-72, XerC/XerD-like | |
A076 | ISAba1, blaADC-75 | ISAba1, blaOXA-69 | blaTEM-1D | |
A077 | ISAba1, blaADC-30 | blaOXA-66 | XerC/XerD-like, blaOXA-24/40, XerC/XerD-like | |
A078 | blaADC-76 | blaOXA-68 | XerC/XerD-like, ISAba31, blaOXA-72, XerC/XerD-like | IS6-family, blaADC-77 |
A079 | ISAba1, blaADC-73 | blaOXA-66 | blaOXA-23 (Tn2006) | blaTEM-1D |
A080 | ISAba1, blaADC-73 | blaOXA-66 | blaOXA-23 (Tn2006) | blaTEM-1D |
A082 | ISAba1, blaADC-78 | blaOXA-69 | blaOXA-23 (Tn2006) | blaTEM-1D |
A084 | ISAba1, blaADC-30 | blaOXA-66 | blaOXA-23 (Tn2006) | blaTEM-1D |
A085 | ISAba1, blaADC-79 | blaOXA-71 | blaOXA-23 (Tn2006) | |
A086 | ISAba1, blaADC-73 | blaOXA-66 | blaOXA-23 (Tn2006) | blaTEM-1D |
A087 | ISAba1, blaADC-30 | blaOXA-66 | XerC/XerD-like, blaOXA-24/40, XerC/XerD-like | |
A089 | ISAba1, blaADC-73 | blaOXA-66 | blaOXA-23 (Tn2006) | |
A091 | ISAba1, blaADC-30, ISAba1 | blaOXA-66 | blaOXA-23 (Tn2006) | |
A092 | blaADC-26 | blaOXA-64 | blaOXA-23 (Tn2006) | blaPER-7 |
A093 | blaADC-26 | blaOXA-64 | blaOXA-23 (Tn2006) | blaPER-7 |
A094 | blaADC-26 | blaOXA-64 | blaOXA-23 (Tn2006) | |
A095 | ISAba1, blaADC-73 | blaOXA-66 | blaOXA-23 (Tn2006) | blaTEM-1D |
A096 | blaADC-26 | blaOXA-64 | blaOXA-23 (Tn2006) | blaPER-7 |
A097 | blaADC-26 | blaOXA-64 | blaOXA-23 (Tn2006) | blaPER-7 |
A099 | ISAba1, blaADC-80 | blaOXA-94 | ISAba2, ΔISAba3, blaOXA-467, ISAba3 | blaTEM-1D, blaCARB-8 |
A100 | ISAba125, blaADC-81 | blaOXA-92 | XerC/XerD-like, ISAba31, blaOXA-72, XerC/XerD-like | blaTEM-1D |
A101 | ISAba1, blaADC-73 | blaOXA-66 | blaOXA-23 (Tn2006) | blaTEM-1D |
A105 | ISAba1, blaADC-74 | blaOXA-66 | XerC/XerD-like, ISAba31, blaOXA-72, XerC/XerD-like |
TABLE 4.
Strain | 16S rRNA methylase gene | Aminoglycoside-modifying enzyme(s) (genetic context) |
||
---|---|---|---|---|
aphA1 | aphA6 | Other | ||
A068 | armA | |||
A069 | armA | IS6-family, ΔIS26, aacC2, ΔISkpn11 | ||
A070 | armA | aphA1b (Tn6020a-2), ΔaphA1b (Tn6020b-2) | intI, aacC1, orfP, orfP, orfQ, aadA1; ΔintI1, aacA4, catB8, aadA1 | |
A071 | armA | aphA1b (Tn6020b-1) | ΔintI1, aacA4, catB8, aadA1 | |
A072 | armA | aphA1b (Tn6020a-1) | ||
A074 | aphA1b (Tn6020a-2) | aphA6 (TnaphA6)a | intI1, aacC1, orfP, orfQ, aadA1 (1st copy); intI1, aacC1, orfP, orfQ, aadA1 (2nd copy) | |
A076 | aphA1b (Tn6020a-3) | intI1, aacC1, orfP, orfQ, aadA1 | ||
A077 | intI1, aacC1, orfP, orfP, ΔorfQ | |||
A078 | aphA6 (TnaphA6) | aadB | ||
A079 | armA | aphA1b (Tn6020a-1) | ||
A080 | armA | aphA1b (Tn6020a-1) | ||
A082 | aphA1b (Tn6020a-2) | intI1, aacC1, orfP, orfQ, aadA1; IS6-family, ΔISAba14, aacC2, abc-ATPase, orf2, orf3, ΔISCfr1, IS6-family | ||
A084 | aphA1b (Tn6020a-1) | intI, aacC1, orfP, orfP, orfQ, aadA1 | ||
A085 | intI1, aadB | |||
A086 | armA | aphA1b (Tn6020a-1) | ||
A087 | intI1, aacC1, orfP, orfP, ΔorfQ | |||
A089 | armA | |||
A091 | armA | aphA1b (Tn6020b-1) | ΔintI1, aacA4, catB8, aadA1 | |
A092 | armA | aphA6 (TnaphA6)b | IS6-family, ΔIS26, aacC2, ΔISkpn11 | |
A093 | armA | IS6-family, ΔIS26, aacC2, ΔISkpn11 | ||
A094 | armA | aphA6 (TnaphA6)b | IS6-family, ΔIS26, aacC2, ΔISkpn11 | |
A095 | armA | aphA1b (Tn6020a-1) | aphA6 (TnaphA6)b | |
A096 | armA | aphA6 (TnaphA6)b | IS6-family, ΔIS26, aacC2, ΔISkpn11 | |
A097 | armA | aphA6 (TnaphA6)b | IS6-family, ΔIS26, aacC2, ΔISkpn11 | |
A099 | aphA1b (Tn6020a-2) | aphA6 (TnaphA6)b | intI1, aacC1, orfP, orfP, orfQ, aadA1 | |
A100 | aphA1b (Tn6020a-2) | aphA6 (TnaphA6) | ΔintI1, aacA4, aacC1, orfP, orfQ, aadA1 | |
A101 | aphA1b (Tn6020a-1) | aphA6 (TnaphA6-like)b,c | ||
A105 | aphA1b (Tn6020a-2) | aphA6 (TnaphA6)a | intI1, aacC1, orfP, orfP, orfQ, aadA1; intI1, aacC1, orfP, orfQ, aadA1 |
Inserted at a novel location on an aci6-carrying plasmid similar to pAb-G7-2.
Inserted at the same location at which it is inserted in pAb-G7-2.
Associated with a deletion of 1,165 bp in the host plasmid.
Genetic surroundings of antibiotic resistance genes.
The blaOXA-23 gene was located in Tn2006 in 19/20 of the blaOXA-23-positive isolates (Table 3). Tn2006 was carried on AbaR4-like resistance islands interrupting the comM gene in many of the isolates, including all the CC25 isolates (data not shown). Only one isolate (A071) carried the blaOXA-23 gene on a Tn2009 transposon, inserted chromosomally at the same position where it is located in A. baumannii strain MDR-ZJ06 (GB accession number CP001937) (29). The blaOXA-467 gene was surrounded by upstream and downstream ISAba3 elements, of which the upstream copy was interrupted by another IS element, namely, ISAba2 (Table 3). A similar genetic structure was found in A. baumannii isolate MAD (GB accession number AY665723) and in several A. baumannii plasmids, such as pOUR, pABNA1, pABNA2, and pACICU1 (GB accession numbers NG_036424, NG_036787, NG_036788, and CP000864, respectively) (30). A linkage between blaOXA-467 and a contig carrying the AciX replication gene, representing GR10 of the A. baumannii plasmids, was detected (25).
All the blaOXA-24/40 and blaOXA-72 genes were flanked by XerC/XerD-like sites and were located on GR2 (Aci1)-type plasmids (see Tables S4 and S5 in the supplemental material) (25). The blaOXA-24/40-carrying plasmids showed >99% identity to pABVA01 and pMMCU3 (GB accession numbers FM210331 and GQ904227, respectively), which were recovered from A. baumannii strains detected in Italy and Spain (31, 32), whereas the blaOXA-72-carrying plasmids were more related to pAB-NCGM253 (GB accession number AB823544), a plasmid carried by A. baumannii strains from Japan (33). Interestingly, the replication genes of the blaOXA-24/40- and blaOXA-72-carrying plasmids shared only 86% nucleotide sequence identity to each other (see Fig. S3 in the supplemental material). A novel IS element was inserted upstream of blaOXA-72 in the four blaOXA-72-positive isolates, although they were recovered in 3 different cities in Sweden (Table 3 and Fig. 3). The new IS, designated ISAba31, was 858 bp long and possessed only one gene encoding a transposase of 248 amino acids with putative transposase of the IS4/5 family and transposase DDE domains (pfam13340 and pfam13586, respectively). ISAba31 has imperfect terminal inverted repeats of 16 bp (GGGTGTGTTGACACTT and AAGTGTCAACAGACCC). The insertion of ISAba31 generated a 2-bp AT duplication in the target site. Three additional copies of ISAba31 were present in the genome of one of our isolates (isolate A100). ISAba31 was not present in the genome of the other isolates, except for A099, which carried four copies of an ISAba31-like element (data not shown).
The armA gene was located on the chromosome in nine isolates (ST2 and ST215) and on plasmids in seven isolates (ST25) (Table 5). All the nine chromosomal armA genes were carried on genetic structures interrupting the histone acetyltransferase HPA2 gene (Fig. 4). In two of these isolates (A071 and A091), the genetic context of armA represented a composite transposon, labeled Tn6279, delineated by two peripheral copies of IS26 (Fig. 4A). Tn6279 was 20,959 bp long and included two segments sharing an internal copy of IS26. The first segment, Tn6020b-1, was 2,706 bp long and carried only the aphA1b gene. The second segment, Tn1548-like-1, was 20,862 bp long and carried six antimicrobial resistance genes [aacA4, catB8, aadA1, armA, msr(E), and mph(E)], with three of them (aacA4, catB8, and aadA1) being part of a class 1 integron. The Tn1548-like-1 segment also carried ISCR1, two transposase genes (tnpU and tnpD), one open reading frame (orfTn1548) encoding a hypothetical protein, and a truncated plasmid replication initiator gene (ΔrepTn1548). Tn6279 was surrounded by a direct repeat of 8 bp (AGGATGAG). Isolate A070 carried a very similar structure, Tn6279-like, characterized by having a truncated copy of aphA1b on the first segment, Tn6020b-2 (Table 5). Tn6279-like was also associated with an upstream deletion of 29,151 bp in the chromosome of A070 (Fig. 4A).
TABLE 5.
armA element | Genetic structure | Strain(s) | Locationb | TSDa | Comment |
---|---|---|---|---|---|
Tn6279 | IS26, ΔIS26, aphA1b, IS26, ΔintI1, aacA4, catB8, aadA1, qacEΔ1, sul1, ISCR1, tnpU, armA, tnpD, msr(E), mph(E), orfTn1548-ISAba24, ΔrepTn1548, IS26 | A071, A091 | Chromosome | Yes | |
Tn6279-like | IS26, ΔIS26, ΔaphA1b, IS26, ΔintI1, aacA4, catB8, aadA1, qacEΔ1, sul1, ISCR1, tnpU, armA, tnpD, msr(E), mph(E), orfTn1548-ISAba24, ΔrepTn1548, IS26 | A070 | Chromosome | ND | Upstream deletion of 29,151 bp in the host chromosome |
ΔTn6279 | ΔtnpU, armA, tnpD, msr(E), mph(E), orfTn1548-ISAba24, ΔrepTn1548, IS26 | A072, A079, A080, A086, A089 | Chromosome | ND | Upstream deletion of 3,937 bp in the host chromosome and 7,649 bp in the inserted element itself |
ΔTn6279/IS26 | ΔtnpU, armA, tnpD-IS26, msr(E), mph(E), orfTn1548-ISAba24, ΔrepTn1548, IS26 | A095 | Chromosome | ND | Similar to ΔTn6279 but with an additional copy of IS26 interrupting the tnpD gene |
Tn1548-like-2 | ΔintI1, arr-2, cmlA7, ΔqacE1, sul1, ISCR1, blaPER-7, gst, Δabct, ΔΔqacE1, sul1, ISCR1, tnpU, IS1999, armA, tnpD, msr(E), mph(E), orfTn1548, ΔrepTn1548, IS26 | A068, A092, A093, A096, A097 | Plasmid | NA | Related to the Tn1548-like-1 segment of Tn6279 |
Tn1548-like-2-Δ1 | Δgst, Δabct, ΔΔqacE1, sul1, ISCR1, tnpU, IS1999, armA, tnpD, msr(E), mph(E), orfTn1548, ΔrepTn1548, IS26 | A069 | Plasmid | NA | Representing a truncated form of Tn1548-like-2; Δgst was 237 bp |
Tn1548-like-2-Δ2 | Δgst, Δabct, ΔΔqacE1, sul1, ISCR1, tnpU, IS1999, armA, tnpD, msr(E), mph(E), orfTn1548, ΔrepTn1548, IS26 | A094 | Plasmid | NA | Representing a truncated form of Tn1548-like-2; Δgst was 314 bp |
TSD, target site duplication; ND, not detectable due to the upstream deletion; NA, not applicable.
All the chromosomal armA-positive elements were inserted in orfHPA2, a histone acetyltransferase gene.
PCR assays using outwards internal primers, which were followed by sequence analysis of the PCR products, demonstrated the co-occurrence of circular forms of the Tn1548-like-1 and Tn6020b segments of Tn6279 as well as a circular form of the entire Tn6279 transposon, where only one copy of IS26 was detected on each circular form (Fig. 4B). Furthermore, PCR assays using external primers on the sides of the insertion site showed that Tn6279 was completely not present or was replaced by only one copy of IS26 in parts of the population of each isolate. Concurrently, the occurrence of Tn1548-like-1, unaccompanied by Tn6020b, was also detected.
On the other hand, a truncated version of the Tn6279 transposon, ΔTn6279, was detected in the other six isolates carrying a chromosomal armA gene (Table 5). ΔTn6279 was formed by an upstream deletion of 11,586 bp, removing 3,937 bp of the host chromosome and 7,649 bp of the Tn6279 transposon itself (Fig. 4A). The tniD gene was interrupted by an extra copy of IS26 in isolate A095. Interestingly, orfTn1548 was interrupted by ISAba24 in all the isolates with a chromosomally located armA gene regardless of whether the transposon was complete or partial.
The seven plasmid-mediated armA genes were carried on configurations showing a considerable structural similarity to the Tn1548-like-1 segment of Tn6279 (Table 5). Five of these isolates had their armA carried on a configuration of 23,037 bp, labeled Tn1548-like-2, in which the aacA4, catB8, and aadA1 gene cassettes of Tn6279 were replaced by arr-2 and cmlA7. In addition, Tn1548-like-2 was characterized by the occurrence of an extra segment carrying blaPER-7 and a second copy of ISCR1. Internal deletions of 7,984 and 7,907 bp were detected in the other two isolates (A069 and A094, respectively), creating the Tn1548-like-2-Δ1 and -Δ2 configurations, respectively. Both the complete and truncated forms of Tn1548-like-2 had an IS1999 element inserted between tnpU and the armA gene. All these structures (namely, Tn1548-like-2, Tn1548-like-2-Δ1, and Tn1548-like-2-Δ2) were carried on large plasmids where they were surrounded by a configuration of 11,269 bp carrying a DNA methylase gene, few open reading frames encoding hypothetical proteins, parA, parB, sul2, and the ISCR2 element on the right side and a configuration of 3,477 bp carrying a resolvase gene and a second ISCR2 element on the left side. Interestingly, these armA-positive structures also coexisted as self-standing circular forms disconnected from the host plasmid (Fig. 4C).
The aacC1, aacA4, and aadA1 genes were always carried on class 1 integrons, making four different arrays of gene cassettes (Table 4). The first array (aacA4, catB8, aadA1) was detected in three isolates and was located near the armA gene, as mentioned above. The second array (aacC1, orfP, orfQ, aadA1) was present in four isolates, where it was located in an AbaR3-like island (data not shown). The third array (aacC1, orfP, orfP, orfQ, aadA1) was present in an AbaR3- or AbGR12-like island in four isolates. A partial version of this array, due to an IS26-mediated deletion, was detected in the AbGR12-like island in 2 additional isolates (A077 and A087). The fourth array (aacA4, aacC1, orfP, orfQ, aadA1) was carried by only one isolate (A100), where it was located in an AbaR3-like island.
The aadB gene in isolate A085 was also carried on a class 1 integron, which was located on a distinctive genetic structure of 18,625 bp named Ab-ST3-aadB (Fig. 5). In contrast, the aadB gene in isolate A078 was not located on an integron, although it was part of a gene cassette. Instead, this aadB gene was carried on a plasmid of 6,078 bp showing 100% nucleotide sequence identity to pRAY*-v1 (GB accession number JF343536). The aacC2 gene, detected in seven isolates, was not carried on class 1 integrons (Table 4). In six isolates, aacC2 was surrounded by IS elements in a structure showing 100% nucleotide sequence identity to a corresponding sequence in A. baumannii AB5256 (GB accession number AHAI01000050). Noticeably, these six aacC2-positive isolates and strain AB5256 belonged to ST25 (data retrieved from the GB sequence). The last aacC2 gene, in isolate A082, was surrounded by different IS elements, where it was located next to a gene encoding an ABC-ATPase protein and two open reading frames encoding hypothetical proteins.
The aphA1 gene was surrounded by IS26 elements in all our positive isolates (Fig. 6). Five different assemblies were defined in our isolates, including two assemblies carried by one isolate (A070) (Fig. 6A). The first assembly, Tn6020a-1, was present in seven isolates that were all from CC2 (Table 4). In this assembly, aphA1b was transcribed in the opposite direction compared to the surrounding IS26 elements, and the spacers between aphA1b and the upstream and downstream IS26 elements were 66 and 372 bp, respectively. Tn6020a-1 showed a nucleotide sequence identity of 99 to 100% to a few isolates in the GB databases, such as Proteus mirabilis strain PmCHA and A. baumannii strain ab929679598 (GB accession numbers KJ411925 and JMOT01000069, respectively).
The second assembly, detected in six isolates from different CCs, was almost identical to Tn6020a-1, except that the downstream IS26 was truncated by another copy of IS26. This assembly, designated here as Tn6020a-2 only for the use of this article, showed 100% structural and nucleotide sequence identity to Tn6020 (representing the endorsed designation of this structure), which has been described among several A. baumannii isolates from Australia (9). The third assembly, Tn6020a-3, was also related to Tn6020a-1. It was characterized by a downstream spacer of only 351 bp and was present in one isolate (A076). In contrast to Tn6020a-1, -2, and -3, the aphA1b gene in Tn6020b-1 and -2 was transcribed in the same direction as the two intact peripheral IS26 elements. The upstream IS26 was truncated by another copy of IS26, and the spacer between aphA1b and the downstream IS26 element was only 49 bp. Tn6020b-1, detected in two isolates, was found to be plasmid mediated in Escherichia coli pMUR050 (GB accession number AY522431) and A. baumannii/p2BJAB07104, A. baumannii/p3BJAB0868, and A. baumannii/pMDR-ZJ06 (GB accession numbers CP003907, CP003908, and CP001938, respectively). Lastly, Tn6020b-2 was carried by only one isolate (A070) and was identical to Tn6020b-1, except that it lacked the upstream spacer and the first 94 bp of aphA1b.
Likewise, aphA6 was always surrounded by ISAba125 elements (Fig. 7). In 10 isolates, aphA6 was surrounded by two copies of ISAba125, creating a TnaphA6a transposon, similar to what has previously been found on a variety of A. baumannii plasmids, such as pWH8144, pBJAB0715, pAb-G7-2, pD72-2, and pD46-3 (GB accession numbers NG_041543, CP003848, KF669606, KM051846, and KM977710, respectively). In one isolate (A101), the downstream ISAba125 was truncated by another ISAba125, producing the TnaphA6-like transposon with a genetic structure that has not been reported before (Fig. 7A).
DISCUSSION
International clones and limited outbreaks.
Along with the extensive worldwide dissemination of CC2 (2), nearly half of our isolates belonged to this clone. Fine molecular typing demonstrated that four of the CC2 isolates (A072, A079, A080, and A086) represented an outbreak of infections taking place in one county of Sweden between September 2012 and April 2013 (Table 1; see also Fig. S2 in the supplemental material). As in previous studies, an epidemiological linkage between the CC2 clone and the blaOXA-66 and blaADC-30 variants was detected (33, 34). Interestingly, seven of the CC2 isolates carried blaADC-73, a novel variant of blaADC with a sequence identity of 1,151/1,152 nucleotides compared to the sequence of blaADC-30. blaADC-73 has previously been detected in the genome of only a few A. baumannii isolates, such as AC12 and PKAB07 (35, 36). Of note, both AC12 and PKAB07 also belong to CC2 (data retrieved from the GB sequences).
The existence of seven CC25 isolates in our collection was probably biased by the occurrence of another small outbreak of infections that took place in one county in August 2013. SNP-based phylogenetic analysis and PFGE also confirmed the occurrence of this outbreak (see Fig. S2 in the supplemental material). The findings of our study are consistent with a growing number of reports describing CC25 to be a highly successful clone with an extensive international spread (2, 37, 38). As described elsewhere, the blaOXA-64 and blaADC-26 variants have generally been characteristic for the CC25 clone (34, 38).
Although the occurrence of international clone CC1 has generally been decreasing (2), three of our isolates belonged to this clone. However, the three CC1 isolates carried different variants of the blaADC gene and belonged to different branches according to the SNP-based phylogenetic analysis and PFGE results. Similarly, the epidemiology of the two ST636 isolates indicated the occurrence of independent acquisitions. Interestingly, the ST215 isolate carried both blaOXA-66 and blaADC-30, indicating that it could be a remote subclone of CC2. One isolate belonged to ST23/CC10, a clone that has so far been restricted to Europe and Australia (2). Two Swedish isolates from our previous study in 2011 also belonged to CC10 (14). Nonetheless, an epidemiological connection between the isolates could not be proposed due to the long gap in the time of acquisition.
According to our knowledge, no formalized numbering scheme has been published for the blaADC gene. The gene is also not included in the Lahey Clinic databases of β-lactamases (http://www.lahey.org/Studies/). Accordingly, we made a table of the currently available ADC variants that have been fully sequenced (see Table S6 in the supplemental material). Since blaADC-72 was the latest variant present in GenBank, our novel variants were assigned the numbers 73 to 81. Two blaADC variants with different amino acid sequences were concomitantly designated blaADC-57 (GB accession numbers JQ037817 and HQ258925). In order to avoid duplications, blaADC-57 was assigned to the variant that was detected in two A. baumannii isolates from East Africa (37). It is important to state that since blaADC is an ampC gene intrinsic in all the Acinetobacter spp., a new designation (such as ampCAc) is probably required for precise terminology.
Resistance to cefotaxime and ceftazidime.
In line with the findings of previous studies, ISAba1-blaADC was the main mechanism of resistance to cefotaxime and ceftazidime in our isolates (33, 39). Of note, one of the isolates (A091) carried a second copy of ISAba1 located ∼2,000 bp downstream of the blaADC gene. The insertion of the two copies of ISAba1 most likely took place independently since each ISAba1 had its own 9-bp target site duplication. However, the two ISAba1 copies constructed a genetic structure that could act as a potential composite transposon in the same way that the transposon recently identified by Hamidian and Hall in a few A. baumannii isolates from Australia does (39). The ISAba125-blaADC-81 element showed 100% nucleotide sequence identity to a sequence present in A. baumannii strain A388, obtained in Greece, including the GCCCCTGCATATGGC internal duplication in blaADC-81 (GB accession number JQ684178) (6). The DNA sequences flanking the acquired blaADC-77 gene, present in isolate A078, included an upstream IS6-family element, similar to the genetic structure that has previously been described in Oligella urethralis (40). However, the occurrence of a downstream IS1009 interrupted by another IS6-family element was present only in our isolate and not in the O. urethralis strain. The nucleotide sequence identity of the internal segment shared by the two structures was 99.8%. A possible origin for this internal segment was found in the draft genome of A. baumannii isolate NIPH 1734 (GB accession number APOX01000011), in which blaADC was most likely intrinsic (data not shown).
Six of the cefotaxime- and ceftazidime-resistant isolates carried blaPER-7, and interestingly, all of them belonged to ST25. The increased activity of blaPER-7 against broad-spectrum cephalosporins has been reported in an A. baumannii isolate from France and an ST25 isolate from the United Arab Emirates (UAE) (38, 41). The French isolate probably also belonged to ST25 since it carried the characteristic blaOXA-64 gene, as mentioned in a previous paragraph. As in the UAE strain, the spontaneous loss of the blaPER-7 gene and the nearby integron took place in one of the five isolates representing the Östergötland ST25 outbreak strain, leaving this isolate susceptible to ceftazidime (41).
Acquisition and construction of Tn6279.
Only one copy of IS26 was inserted in the orfHPA2 gene in the genomes of A. baumannii strains BJAB07104 and BJAB0868 (GB accession numbers CP003846 and CP003849, respectively). The occurrence of a target site duplication of 8 bp indicated that the acquisition of this IS26 copy, representing the first step in the acquisition of Tn6279, was mediated by a typical transposition event. The second step involved the acquisition of Tn1548-like-1, as demonstrated by our results and in A. baumannii strains TYTH-1 and MDR-TJ (GB accession numbers CP003856 and CP003500, respectively), in which the orfHPA2 gene was interrupted only by Tn1548-like-1. The acquisition of Tn1548-like-1 was most likely mediated by a homologous recombination event between the IS26 copy that was already present in this location and a second copy of IS26 carried on a circular form of Tn1548-like-1 (42). This segment was labeled on the basis of the similarity of its genetic structure to that of Tn1548 (GB accession number JN225877), a transposon that has repeatedly been found in the Enterobacteriaceae family (43, 44). The only difference between Tn1548 and our derivative, Tn1548-like-1, was in the gene cassettes of their class 1 integrons. Since the two segments of Tn6279 shared only one in-between IS26 copy, the acquisition of Tn6020b-1, representing the third and last step in the acquisition of Tn6279, was also mediated by a homologous recombination event taking place between the left-sided IS26 copy of Tn1548-like-1 and a copy of IS26 carried on an intermediate circular form of Tn6020b-1 (45).
A previous study has reported the chromosomal occurrence of Tn6279 in A. baumannii strain NCGM 237 (GB accession number AP013357), representing 49 A. baumannii isolates collected by different hospitals in Japan (33). However, Tn6279 in NCGM 237 was present at a different location and was not surrounded by an 8-bp duplication, most likely because the acquisition took place using a chromosomal IS26 element inserted from the beginning without creating a target site duplication. A 20-kb Tn6279-derived plasmid was detected in strains BJAB07104 and BJAB0868 (GB accession numbers CP003907 and CP003908, respectively) (46). A similar plasmid equipped with a different array of gene cassettes was present in A. baumannii strain MDR-ZJ06 (GB accession number CP001938). A structure related to Tn6279 was also found to be inserted in a large plasmid of 57 kb held by an Escherichia coli isolate (GB accession number AY522431) (44). On the other hand, ΔTn6279 was found in the genome of A. baumannii strain PKAB07 (GB accession number CP006963), reported to be a carbapenem-resistant isolate recovered from India in 2011-2012 (36). Of note, all these armA-positive A. baumannii strains, namely, TYTH-1, MDR-TJ, BJAB07104, BJAB0868, NCGM 237, MDR-ZJ06, and PKAB07, belonged to CC2 and were isolated from East Asia (16, 46–48; data retrieved from the GB sequences).
Our armA-positive plasmids showed a close structural similarity to pIOMTU433 (GB accession number AP014650), recovered from an A. baumannii isolate obtained in Japan, and pAB04-1 (GB accession number CP012007), carried by an A. baumannii isolate responsible for an outbreak of infections in Canada, although it had a history of import from India (49). In addition to the geographic dispersal, the last two isolates did not belong to CC25 (49; data retrieved from the GB sequences). The ΔrepTn1548 replication gene of the Tn1548-like elements and their corresponding circular forms shared nucleotide sequence similarities of 85 to 90% with genes encoding the plasmid replication proteins Aci7 (GB accession number NG_040962) and Aci3 (GB accession number NG_040963). Accordingly, ΔrepTn1548 should probably be classified into group 3 using the AB-PBRT system (25).
Different genetic environments for aadB.
On the basis of their structural similarities, the aadB-positive pRAY*-v1 plasmid was reported to be a derivative of pRAY, which was first detected in an Acinetobacter species isolate recovered in South Africa (50). Later on, different variants of pRAY, including pRAY*-v1, were detected among several Acinetobacter species isolates from Australia (8, 51, 52). A similar plasmid was also present in one A. baumannii strain isolated in the Netherlands in 1984 (52). These plasmids were equipped with the mobA and mobC mobilization genes, but there was no gene encoding a potential replication initiation protein. The plasmids also carried a gene encoding the Abi-like protein (pfam07751) involved in bacteriophage resistance mediated by abortive infection in Lactococcus species (53).
The Ab-ST3-aadB structure carried a segment that had probably been obtained from one of the IncP1α plasmids, such as pTB11 (GB accession number AJ744860), without the ISTB11 element, which were detected in uncultured bacteria or Pseudomonas aeruginosa (Fig. 5A) (54, 55). Several genes were identified on this segment, including the ssb-trfA operon, involved in initiation of plasmid replication, and the tetA tetracycline resistance gene (55). It is important to mention that the nucleotide sequence of the tetA gene in Ab-ST3-aadB (isolate A085) had 8 point mutations compared to the sequences of the tetA genes of our other isolates, such as A082 and A099 (see Fig. S4 in the supplemental material). In contrast to the structures of the IncP1α plasmids, the ssb gene was truncated by IS6100, and many other genes, including the origin of vegetative replication (oriV), were missing in our structure (55).
The other main segment of Ab-ST3-aadB was derived from a different group of plasmids, such as pSN254b (GB accession number KJ909290), detected in a fish-pathogenic strain of Aeromonas salmonicida subsp. salmonicida (56). However, a different class 1 integron gene cassette was detected on plasmid pSN254b. This segment included IS5075-like, Tn1721-like (tnpA-tnpR), and class 1 integron (intI1-aadB-ΔqacE-sul1-orf5) regions. Interestingly, this segment ended with an IS6100 element, most likely representing the same copy of IS6100 that truncated ssb of the first segment. IS6100 was then interrupted by an IS26 element, associated with the 8-bp target site duplication (Fig. 5B). Similar to the findings for Tn6279, PCR assays demonstrated the occurrence of an intermediate circular form of Ab-ST3-aadB and showed that part of the population of this isolate carried an IS26 element only in the insertion site.
Ab-ST3-aadB showed 100% nucleotide sequence identity to sequences from A. baumannii strain AB4857 (GB accession number AHAG01000030). Nonetheless, AB4857 had a deletion of 8,067 bp in the adjacent downstream region compared to the sequence of our isolate (Fig. 5C). The absence of surrounding target site duplications both in A085 and in AB4857 indicated that the acquisition of Ab-ST3-aadB was due to an IS26-mediated homologous recombination event involving the circular form of Ab-ST3-aadB and an IS26 copy already present in the chromosome (42). During the acquisition process, the inserted Ab-ST3-aadB became flanked by two copies of IS26, splitting the IS6100 element into two parts (Fig. 5C and D). Ab-ST3-aadB has broadly and exclusively been present in A. baumannii isolates belonging to ST3. The isolate carrying Ab-ST3-aadB in our collection also belonged to ST3, proposing that this element represents a genetic marker with a potential use in tracking the occurrence of ST3 isolates. A previous study reported on the natural transformation of Ab-ST3-aadB from A. baumannii 064 into the genome of Acinetobacter baylyi ADP1 (GB accession number CR543861), resulting in transformant A. baylyi Ab(II)3 (GB accession number JX041889) (57). In the A. baylyi recipient, Ab-ST3-aadB interrupted a gene (labeled ACIAD0480, according to GB records), where the acquisition created a target site duplication of 8 bp (Fig. 5D). Accordingly, the acquisition of Ab-ST3-aadB by A. baylyi Ab(II)3 was due to natural transformation followed by standard transposition of the entire IS26 composite transposon (57).
Characterization of the Tn6020 and TnaphA6 transposons.
All the aphA1-positive isolates in our collection carried aphA1b, a variant that was first detected in a Proteus rettgeri strain more than 40 years ago (58). Previous studies have reported the occurrence of aphA1b surrounded by at least two complete copies of IS26 (9, 27). The genetic context of Tn6020a-1 in isolate A084 (CC2) and Tn6020a-2 in isolate A070 (CC215) corresponded to the AbGR-12 island (Fig. 6B). The occurrence of Tn6020a-2 in AbGR-12 was previously described in A. baumannii strains WM99c and A94, from the CC2 collection of A. baumannii isolates obtained in Australia (27). However, the replacement of Tn6020a-2 by Tn6020a-1 in this location was novel and highlighted the plasticity of the AbGR-12-like islands. On the other hand, Tn6020a-2 in isolates A082 (CC1), A99 (ST85), and A100 (CC1) and Tn6020-3 in isolate A076 (CC1) were all located in an AbaR3-like background, similar to what has previously described in a number of CC1 A. baumannii strains, such as RUH875, WM98, AB0057, and AYE (9). In addition to aphA1, the AbGR-12- and AbaR3-like islands have frequently been equipped with blaTEM-D1 and a class 1 integron(s) (48). Tn6020a-1 was also linked to blaTEM-D1 in the other six positive isolates (along with isolate A084). However, the whole construct was not carried in either an AbaR3- or an AbGR12-like island in these isolates. Noticeably, none these six isolates carried class 1 integrons (Table 4).
As described above and in previous studies, Tn6020b-1 and Tn6020b-2 were associated with the armA gene (16, 46). Circular forms of Tn6020 were detected in most of the aphA1-positive isolates (Fig. 6C). The size of each circular form was consistent with the length of the corresponding assembly (see Fig. S5 in the supplemental material). Tn6020 was consistently displaced in a fraction of the population of each of these isolates. Our results are in line with those of a number of previous studies reporting on the readiness of the IS26-flanked composite transposons to be excised out, leading to the formation of circular intermediate forms (59, 60). A recent study demonstrated that the acquisition of IS26-based circular forms was RecA independent (42). Instead, it was reliant on the presence of an intact tnp26 transposase gene. According to Harmer et al. (42), the frequency of being integrated was 60-fold higher when the target site contained a parallel IS26 element.
The aphA6 kanamycin and amikacin resistance gene was first detected in A. baumannii strain BM2580, isolated in 1984, in which the gene was carried on a 63-kb self-transferable plasmid (61). Structural comparisons of the previously detected aphA6-positive plasmids demonstrated a distinctive construction for pWH8144 and pBJAB0715, both of which are equipped with TnaphA6 and blaOXA-58 (46, 62). On the other hand, the pAb-G7-2, pD72-2, and pD46-3 plasmids had a common aci6-positive backbone, although they were detected in isolates belonging to three different CCs, namely, CC1, CC2, and CC25 (8, 63).
TnaphA6 in six of our isolates was inserted at the same location at which it was located in pAb-G7-2 (64). A third copy of ISAb125 was present close to TnaphA6 in the ST25 isolates (Fig. 7A). TnaphA6-like was also inserted at this location, but it was associated with an upstream deletion of 1,165 bp in the host plasmid. In the two ST636 isolates, TnaphA6 was carried on a plasmid of ∼70 kb showing a considerable structural similarity to pAb-G7-2, pD72-2, and pD46-3, although it was inserted at a new site and in the opposite direction compared to its location and direction in pAb-G7-2 (Fig. 7B). This plasmid, labeled pA105-1, carried a type IV secretion system and at least one toxin-antitoxin system, as previously described for the aci6 plasmids (63). In the remaining two isolates, TnaphA6 was most likely located on a novel carrier, which we were not able to define. As expected, these last two isolates were deprived of aci6 plasmids (see Table S4 in the supplemental material). All the aphA6-positive isolates carried coexisting circular forms of TnaphA6 (Fig. 7C), indicating that ISAba125 (from the IS30 family) had the same ability as IS26 (from the IS6 family) to create enduring intermediate circular forms. All the ISAba125- and IS26-based circular forms that were detected in our study had only one copy of the corresponding IS element. The site of insertion of TnaphA6 in the two ST636 isolates was intact (in one part of the population of each isolate), inserted by only one ISAba125 (in a second part), or inserted by TnaphA6 (in a third part), as illustrated in Fig. 7D.
Overall, our study precisely defined the genetic context of particular aminoglycoside resistance genes in A. baumannii, leading to the identification of a few novel genetic structures, such as Tn6279 and Ab-ST3-aadB, and a number of circular forms related to the IS26 or ISAba125 composite transposons. The potential role of these circular forms in the dissemination of antibiotic resistance genes needs further investigation.
Supplementary Material
ACKNOWLEDGMENTS
We thank all colleagues who generously provided isolates for this study. We also thank Dr. Ruth Hall for text corrections at the proof stage. We thank the team of curators of the Institut Pasteur Acinetobacter MLST system for curating the data and making them publicly available at http://pubmlst.org/abaumannii/. We also thank the curators of the Lahey Clinic databases of β-lactamases (http://www.lahey.org/Studies/), the Tn Number Registry (http://www.ucl.ac.uk/eastman/research/departments/microbial-diseases/tn), and the ISfinder database (www-is.biotoul.fr).
Funding Statement
This work was supported by project grants from the Swedish Research Council (VR-MH 2010-3031, VR-NT 2012-4638, and VR-MH 2013-3878) and from The Kempe Foundations (JCK-1527). The work was performed as part of the Umeå Centre for Microbial Research (UCMR) Linnaeus Program supported by Umeå University and the Swedish Research Council (349-2007-8673). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Footnotes
Supplemental material for this article may be found at http://dx.doi.org/10.1128/AAC.02143-15.
REFERENCES
- 1.Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939–951. doi: 10.1038/nrmicro1789. [DOI] [PubMed] [Google Scholar]
- 2.Karah N, Sundsfjord A, Towner K, Samuelsen O. 2012. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 15:237–247. doi: 10.1016/j.drup.2012.06.001. [DOI] [PubMed] [Google Scholar]
- 3.Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034. doi: 10.1371/journal.pone.0010034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538–582. doi: 10.1128/CMR.00058-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12:826–836. doi: 10.1111/j.1469-0691.2006.01456.x. [DOI] [PubMed] [Google Scholar]
- 6.Hamidian M, Hancock DP, Hall RM. 2013. Horizontal transfer of an ISAba125 activated ampC gene between Acinetobacter baumannii strains leading to cephalosporin resistance. J Antimicrob Chemother 68:244–245. doi: 10.1093/jac/dks345. [DOI] [PubMed] [Google Scholar]
- 7.Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. 2004. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol 53:1233–1240. doi: 10.1099/jmm.0.45716-0. [DOI] [PubMed] [Google Scholar]
- 8.Nigro SJ, Post V, Hall RM. 2011. Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals. J Antimicrob Chemother 66:1504–1509. doi: 10.1093/jac/dkr163. [DOI] [PubMed] [Google Scholar]
- 9.Post V, Hall RM. 2009. AbaR5, a large multiple antibiotic resistance region found in Acinetobacter baumannii. Antimicrob Agents Chemother 53:2667–2671. doi: 10.1128/AAC.01407-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Doi Y, Adams JM, Yamane K, Paterson DL. 2007. Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America. Antimicrob Agents Chemother 51:4209–4210. doi: 10.1128/AAC.00560-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Doi Y, Arakawa Y. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45:88–94. doi: 10.1086/518605. [DOI] [PubMed] [Google Scholar]
- 12.Cho YJ, Moon DC, Jin JS, Choi CH, Lee YC, Lee JC. 2009. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn Microbiol Infect Dis 64:185–190. doi: 10.1016/j.diagmicrobio.2009.02.010. [DOI] [PubMed] [Google Scholar]
- 13.Vila J, Ruiz J, Goni P, Jimenez de Anta T. 1997. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother 39:757–762. doi: 10.1093/jac/39.6.757. [DOI] [PubMed] [Google Scholar]
- 14.Karah N, Giske CG, Sundsfjord A, Samuelsen O. 2011. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages. Microb Drug Resist 17:545–549. doi: 10.1089/mdr.2011.0089. [DOI] [PubMed] [Google Scholar]
- 15.La Scola B, Gundi VA, Khamis A, Raoult D. 2006. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 44:827–832. doi: 10.1128/JCM.44.3.827-832.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44:2974–2976. doi: 10.1128/JCM.01021-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. Document M100-S24 Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
- 18.Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50:4114–4123. doi: 10.1128/AAC.00778-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50:1355–1361. doi: 10.1128/JCM.06094-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43:4328–4335. doi: 10.1128/JCM.43.9.4328-4335.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Simpson JT, Wong K, Jackman SD, Schein JE, Jones SJ, Birol I. 2009. ABySS: a parallel assembler for short read sequence data. Genome Res 19:1117–1123. doi: 10.1101/gr.089532.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. 2006. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 34:D32–D36. doi: 10.1093/nar/gkj014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. 2010. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 54:4168–4177. doi: 10.1128/AAC.00542-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Vila J, Ruiz J, Goni P, Marcos A, Jimenez de Anta T. 1995. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 39:1201–1203. doi: 10.1128/AAC.39.5.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Nigro SJ, Farrugia DN, Paulsen IT, Hall RM. 2013. A novel family of genomic resistance islands, AbGRI2, contributing to aminoglycoside resistance in Acinetobacter baumannii isolates belonging to global clone 2. J Antimicrob Chemother 68:554–557. doi: 10.1093/jac/dks459. [DOI] [PubMed] [Google Scholar]
- 28.Roberts AP, Chandler M, Courvalin P, Guedon G, Mullany P, Pembroke T, Rood JI, Smith CJ, Summers AO, Tsuda M, Berg DE. 2008. Revised nomenclature for transposable genetic elements. Plasmid 60:167–173. doi: 10.1016/j.plasmid.2008.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Zhou H, Zhang T, Yu D, Pi B, Yang Q, Zhou J, Hu S, Yu Y. 2011. Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob Agents Chemother 55:4506–4512. doi: 10.1128/AAC.01134-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Poirel L, Nordmann P. 2006. Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50:1442–1448. doi: 10.1128/AAC.50.4.1442-1448.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.D'Andrea MM, Giani T, D'Arezzo S, Capone A, Petrosillo N, Visca P, Luzzaro F, Rossolini GM. 2009. Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 53:3528–3533. doi: 10.1128/AAC.00178-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Merino M, Acosta J, Poza M, Sanz F, Beceiro A, Chaves F, Bou G. 2010. OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob Agents Chemother 54:2724–2727. doi: 10.1128/AAC.01674-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Tada T, Miyoshi-Akiyama T, Shimada K, Shimojima M, Kirikae T. 2014. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother 58:2916–2920. doi: 10.1128/AAC.01212-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Evans BA, Hamouda A, Towner KJ, Amyes SG. 2008. OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin Microbiol Infect 14:268–275. doi: 10.1111/j.1469-0691.2007.01919.x. [DOI] [PubMed] [Google Scholar]
- 35.Lean SS, Yeo CC, Suhaili Z, Thong KL. 2015. Whole-genome analysis of an extensively drug-resistant clinical isolate of Acinetobacter baumannii AC12: insights into the mechanisms of resistance of an ST195 clone from Malaysia. Int J Antimicrob Agents 45:178–182. doi: 10.1016/j.ijantimicag.2014.10.015. [DOI] [PubMed] [Google Scholar]
- 36.Saranathan R, Tomar A, Sudhakar P, Arunkumar KP, Prashanth K. 2014. Draft genome sequence of a multidrug-resistant Acinetobacter baumannii PKAB07 clinical strain from India belonging to sequence type 195. Genome Announc 2(2):e00184-14. doi: 10.1128/genomeA.00184-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Revathi G, Siu LK, Lu PL, Huang LY. 2013. First report of NDM-1-producing Acinetobacter baumannii in East Africa. Int J Infect Dis 17:e1255–e1258. doi: 10.1016/j.ijid.2013.07.016. [DOI] [PubMed] [Google Scholar]
- 38.Bonnin R, Potron A, Poirel L, Lecuyer H. 2011. PER-7, an extended-spectrum β-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother 55:2424–2427. doi: 10.1128/AAC.01795-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hamidian M, Hall RM. 2014. Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii. J Antimicrob Chemother 69:77–78. doi: 10.1093/jac/dkt312. [DOI] [PubMed] [Google Scholar]
- 40.Mammeri H, Poirel L, Mangeney N, Nordmann P. 2003. Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob Agents Chemother 47:1536–1542. doi: 10.1128/AAC.47.5.1536-1542.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Opazo A, Sonnevend A, Lopes B, Hamouda A, Ghazawi A, Pal T, Amyes SG. 2012. Plasmid-encoded PER-7 β-lactamase responsible for ceftazidime resistance in Acinetobacter baumannii isolated in the United Arab Emirates. J Antimicrob Chemother 67:1619–1622. doi: 10.1093/jac/dks087. [DOI] [PubMed] [Google Scholar]
- 42.Harmer CJ, Moran RA, Hall RM. 2014. Movement of IS26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26. mBio 5:e01801-14. doi: 10.1128/mBio.01801-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Galimand M, Sabtcheva S, Courvalin P, Lambert T. 2005. Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob Agents Chemother 49:2949–2953. doi: 10.1128/AAC.49.7.2949-2953.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Gonzalez-Zorn B, Catalan A, Escudero JA, Dominguez L, Teshager T, Porrero C, Moreno MA. 2005. Genetic basis for dissemination of armA. J Antimicrob Chemother 56:583–585. doi: 10.1093/jac/dki246. [DOI] [PubMed] [Google Scholar]
- 45.Cain AK, Liu X, Djordjevic SP, Hall RM. 2010. Transposons related to Tn1696 in IncHI2 plasmids in multiply antibiotic resistant Salmonella enterica serovar Typhimurium from Australian animals. Microb Drug Resist 16:197–202. doi: 10.1089/mdr.2010.0042. [DOI] [PubMed] [Google Scholar]
- 46.Zhu L, Yan Z, Zhang Z, Zhou Q, Zhou J, Wakeland EK, Fang X, Xuan Z, Shen D, Li QZ. 2013. Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements. PLoS One 8:e66584. doi: 10.1371/journal.pone.0066584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Liu CC, Tang CY, Kuo HY, Lu CW, Chang KC, Liou ML. 2013. The origin of Acinetobacter baumannii TYTH-1: a comparative genomics study. Int J Antimicrob Agents 41:318–324. doi: 10.1016/j.ijantimicag.2012.12.010. [DOI] [PubMed] [Google Scholar]
- 48.Huang H, Yang ZL, Wu XM, Wang Y, Liu YJ, Luo H, Lv X, Gan YR, Song SD, Gao F. 2012. Complete genome sequence of Acinetobacter baumannii MDR-TJ and insights into its mechanism of antibiotic resistance. J Antimicrob Chemother 67:2825–2832. doi: 10.1093/jac/dks327. [DOI] [PubMed] [Google Scholar]
- 49.Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout J. 2013. Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother 57:3085–3091. doi: 10.1128/AAC.00297-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Segal H, Elisha BG. 1997. Identification and characterization of an aadB gene cassette at a secondary site in a plasmid from Acinetobacter. FEMS Microbiol Lett 153:321–326. doi: 10.1111/j.1574-6968.1997.tb12591.x. [DOI] [PubMed] [Google Scholar]
- 51.Gifford B, Tucci J, McIlroy SJ, Petrovski S. 2014. Isolation and characterization of two plasmids in a clinical Acinetobacter nosocomialis strain. BMC Res Notes 7:732. doi: 10.1186/1756-0500-7-732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Hamidian M, Nigro SJ, Hall RM. 2012. Variants of the gentamicin and tobramycin resistance plasmid pRAY are widely distributed in Acinetobacter. J Antimicrob Chemother 67:2833–2836. doi: 10.1093/jac/dks318. [DOI] [PubMed] [Google Scholar]
- 53.Anba J, Bidnenko E, Hillier A, Ehrlich D, Chopin MC. 1995. Characterization of the lactococcal abiD1 gene coding for phage abortive infection. J Bacteriol 177:3818–3823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Haines AS, Jones K, Batt SM, Kosheleva IA, Thomas CM. 2007. Sequence of plasmid pBS228 and reconstruction of the IncP-1α phylogeny. Plasmid 58:76–83. doi: 10.1016/j.plasmid.2007.01.001. [DOI] [PubMed] [Google Scholar]
- 55.Tennstedt T, Szczepanowski R, Krahn I, Pühler A, Schlüter A. 2005. Sequence of the 68,869 bp IncP1α plasmid pTB11 from a waste water treatment plant reveals a highly conserved backbone, a Tn402-like integron and other transposable elements. Plasmid 53:218–238. doi: 10.1016/j.plasmid.2004.09.004. [DOI] [PubMed] [Google Scholar]
- 56.Vincent AT, Trudel MV, Paquet VE, Boyle B, Tanaka KH, Dallaire-Dufresne S, Daher RK, Frenette M, Derome N, Charette SJ. 2014. Detection of variants of the pRAS3, pAB5S9, and pSN254 plasmids in Aeromonas salmonicida subsp. salmonicida: multidrug resistance, interspecies exchanges, and plasmid reshaping. Antimicrob Agents Chemother 58:7367–7374. doi: 10.1128/AAC.03730-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Domingues S, Harms K, Fricke FW, Johnsen PJ, da Silva G, Nielsen KM. 2012. Natural transformation facilitates transfer of transposons, integrons and gene cassettes between bacterial species. PLoS Pathog 8:e1002837. doi: 10.1371/journal.ppat.1002837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Coetzee JN, Datta N, Hedges RW. 1972. R factors from Proteus rettgeri. J Gen Microbiol 72:543–552. doi: 10.1099/00221287-72-3-543. [DOI] [PubMed] [Google Scholar]
- 59.He T, Wang Y, Qian M, Wu C. 2015. Mequindox resistance and in vitro efficacy in animal-derived Escherichia coli strains. Vet Microbiol 177:341–346. doi: 10.1016/j.vetmic.2015.04.007. [DOI] [PubMed] [Google Scholar]
- 60.Wang Y, He T, Schwarz S, Zhou D, Shen Z, Wu C, Wang Y, Ma L, Zhang Q, Shen J. 2012. Detection of the staphylococcal multiresistance gene cfr in Escherichia coli of domestic-animal origin. J Antimicrob Chemother 67:1094–1098. doi: 10.1093/jac/dks020. [DOI] [PubMed] [Google Scholar]
- 61.Lambert T, Gerbaud G, Courvalin P. 1988. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3′-aminoglycoside phosphotransferase. Antimicrob Agents Chemother 32:15–19. doi: 10.1128/AAC.32.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Fu Y, Jiang J, Zhou H, Jiang Y, Fu Y, Yu Y, Zhou J. 2014. Characterization of a novel plasmid type and various genetic contexts of blaOXA-58 in Acinetobacter spp. from multiple cities in China. PLoS One 9:e84680. doi: 10.1371/journal.pone.0084680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Liu CC, Kuo HY, Tang CY, Chang KC, Liou ML. 2014. Prevalence and mapping of a plasmid encoding a type IV secretion system in Acinetobacter baumannii. Genomics 104:215–223. doi: 10.1016/j.ygeno.2014.07.011. [DOI] [PubMed] [Google Scholar]
- 64.Nigro SJ, Holt KE, Pickard D, Hall RM. 2015. Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid. J Antimicrob Chemother 70:1259–1261. doi: 10.1093/jac/dku486. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.